What is SpyGlass Pharma, Inc. Common Stock's Market Cap?

SpyGlass Pharma, Inc. Common Stock's Market Cap is $948.3M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Enterprise Value?

SpyGlass Pharma, Inc. Common Stock's Enterprise Value is $725.1M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's EV / EBITDA?

SpyGlass Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Net Income (TTM)?

SpyGlass Pharma, Inc. Common Stock's Net Income (TTM) is -$56.1M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's EBITDA?

SpyGlass Pharma, Inc. Common Stock's EBITDA is -$61.1M, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM)?

SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.

What is SpyGlass Pharma, Inc. Common Stock's Net Debt?

SpyGlass Pharma, Inc. Common Stock's Net Debt is -$223.1M, based on as-reported figures from SEC (XBRL) filings.

SpyGlass Pharma, Inc. Common Stock (SGP) Financial Statements

SpyGlass Pharma, Inc. Common Stock

SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS

FIGI BBG01HDDMDT4

XNAS · usd

28.35▼ 0.57 (-1.97%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close28.92

Day's Range27.82 – 30.05

52-Week Range17.06 – 32.88

Volume119.3K

Avg Volume78.1K

Share Statistics

Shares Outstanding

Employees65

ExchangeXNAS

Listed2026-02-06

Share count as of July 29, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about SpyGlass Pharma, Inc. Common Stock (SGP)

What is SpyGlass Pharma, Inc. Common Stock's Market Cap?: SpyGlass Pharma, Inc. Common Stock's Market Cap is $948.3M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Enterprise Value?: SpyGlass Pharma, Inc. Common Stock's Enterprise Value is $725.1M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's EV / EBITDA?: SpyGlass Pharma, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Net Income (TTM)?: SpyGlass Pharma, Inc. Common Stock's Net Income (TTM) is -$56.1M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's EBITDA?: SpyGlass Pharma, Inc. Common Stock's EBITDA is -$61.1M, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM)?: SpyGlass Pharma, Inc. Common Stock's Diluted EPS (TTM) is -1.68, based on as-reported figures from SEC (XBRL) filings.
What is SpyGlass Pharma, Inc. Common Stock's Net Debt?: SpyGlass Pharma, Inc. Common Stock's Net Debt is -$223.1M, based on as-reported figures from SEC (XBRL) filings.